A Comparative Study on Immune Protection Efficacy: An HSV-1 Trivalent Antigen Subunit Vaccine Formulated with a Cellular Immunity-Inducing Adjuvant Versus an mRNA Vaccine.

Vaccines (Basel) · 2025 · PMC12474238 · PMID 41012161

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp ≤ 0.001actually significant

Statistical significance was determined as follows: p > 0.05 (nonsignificant, ns), p ≤ 0.05 (significant, *), p ≤ 0.01 (highly significant, **), p ≤ 0.001 (extremely significant, ***), and p ≤ 0.0001 (extremely significant, ****). 3.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.